During the past decade, IRCCS Azienda Ospedaliera-Universitaria di Bologna conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "IRCCS Azienda Ospedaliera-Universitaria di Bologna" are "Acute Kidney Injury" (1 trials), "Gastro-entero Pancreatic Neuroendocrine Tumors" (1 trials), "Hepatorenal Syndrome" (1 trials) and "Liver Cirrhosis" (1 trials). Many other conditions were trialed in "IRCCS Azienda Ospedaliera-Universitaria di Bologna" in a lesser frequency.

Most popular intervention types in "IRCCS Azienda Ospedaliera-Universitaria di Bologna" are "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Azienda Ospedaliera-Universitaria di Bologna" are 2 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Azienda Ospedaliera-Universitaria di Bologna". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in IRCCS Azienda Ospedaliera-Universitaria di Bologna, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Azienda Ospedaliera-Universitaria di Bologna, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".